Status:

UNKNOWN

Evaluation of miRNAs in Endometriosis

Lead Sponsor:

Groupe expert en endometriose-6 centre expert en endometriose

Conditions:

Endometriosis

Endometriosis Fertility

Eligibility:

FEMALE

18-43 years

Brief Summary

We therefore propose a research project based on the prospective evaluation of miRNAs (blood and salivary) in patients with endometriosis diagnosed (by clinical examination and imaging) or suspected o...

Eligibility Criteria

Inclusion

  • \- Patient aged 18 to 43 years old,
  • Patient has dated and signed the consent form,
  • Patient affiliated with the French health care system,
  • Patients with formal endometriosis diagnosed by clinical examination and imaging or suspicion of endometriosis for which the diagnosis is a source of discrepancy between clinical and radiological data,
  • Patient with an indication for medically assisted procreation (MAP) or surgery validated in CPR (in routine care),
  • Patient who has had a pelvic MRI,
  • Patient who completed the symptom and quality of life questionnaires

Exclusion

  • Pregnant patient,
  • Patient infected with the human immunodeficiency virus (HIV),
  • Patient with significant difficulties in reading or writing the French language,
  • Patient with a personal history of cancer,
  • Patient unable to comply with study and/or follow-up procedures,
  • Patient who has objected to the collection of her data.
  • Patient participating in another clinical research study.

Key Trial Info

Start Date :

January 27 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2022

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04728152

Start Date

January 27 2021

End Date

January 1 2022

Last Update

January 28 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sofiane Bendifallah

Paris, France, 75020